Klox Technologies Inc Ipo

Klox technologies inc ipo

Klox technologies inc ipo

December 12, 2019

December 12, 2019

October 29, 2019

October 27-29, 2019

October 22-23, 2019

October 8, 2019

Klox Technologies Inc.

announces the appointment of Mr.

Klox technologies inc ipo

Domenic Serafino and Dr. Richard Markoff to its board of directors – See Full Press Release here

October 4, 2019

Klox Technologies Inc.

Klox Technologies - Using Biophotonics to Treat Unmet Medical Needs: Acne & Chronic Wounds

Announces Completion of the Acquisition of FB Dermatology – See Full Press Release here

September 26-28, 2019

September 23-25, 2019

The MedTech Conference – Boston, United States

August 30, 2019

August 19-22, 2019

August 13, 2019

June 10-15, 2019

June 5-7, 2019

May 16-17, 2019

May 3-4, 2019

March 20-21, 2019

March 15-17, 2019

March 8, 2019

March 7, 2019

LumiHeal was granted the Canadian Medical Device License (MDL) for “the management of post-surgical closed wounds and to help in the prevention of hypertrophic scars and post-surgical wound complications in patients 18 years and older”

March 1, 2019

Fluorescence Biomodulation has been added to various sections in the Journal of Wound Care’s 2019 peer-reviewed International Consensus Document – Implementing TIMERS: the race against hard-to-heal wounds

February 26-27, 2019

February 2-7, 2019

SPIE Photonics West – San Francisco, USA

January 30, 2019

LumiHeal Newsletter – Updates On Our Lead Wound Care Product

January 20-22, 2019

January 7-10, 2019

November 5-7, 2018

Wounds UK – Harrogate, UK

November 4, 2018

September 24-26, 2018

September 12-14, 2018

July 2, 2018

Klox announces positive top-line results from a pivotal study of Phovia™ for the management of Canine Deep Pyoderma – See Full Press Release

June 13-14, 2018

June 4-7, 2018

May 9-11, 2018

May 2-3, 2018

April 25-29, 2018